(S)-2-硝基-6-[[4-(三氟甲氧基)苄基]氧基]-6,7-二氢-5H-咪唑并[2,1-b][1,3]噁嗪

Pretomanid

产品编号.: A235376 CAS号: 187235-37-6
分子式: C14H12F3N3O5 分子量: 359.2574
纯度: 98% MDL NO.:

中文名称:(S)-2-硝基-6-[[4-(三氟甲氧基)苄基]氧基]-6,7-二氢-5H-咪唑并[2,1-b][1,3]噁嗪
CAS号:187235-37-6
中文别名:(S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪;PA-824 抑制剂;(S)-2-硝基-6-[[4-(三氟甲氧基)苄基]氧基]-6,7-二氢-5H-咪唑并[2,1-b][1,3]恶嗪;PA824(S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪;PA-824;PRETOMANID
英文名称:Pretomanid
英文别名:5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (6S)-;PA-824;(S)-PA 824;(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (...;pretomanid;(S)-6-(4-(trifluoromethoxy)benzyloxy)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;PA824;UNII-2XOI31YC4N;2-NITRO-6(S)-[4-(TRIFLUOROMETHOXY)BENZYLOXY]-6,7-DIHYDRO-5H-IMIDAZO[2,1-B][1,3]OXAZINE;(6S)- 6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-Imidazo[2,1-b][1,3]oxazine;(6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine;EOS-60675;(6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine PA-824;PA 824;2XOI31YC4N;MMV688755;(6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine;Pretomanid [USAN:INN];C14H12F3N3O5;AK161427;Pretomanid (USAN/INN);ML;PRETOMANID [MI];(S)-2-NITRO-6-(4-(TRIFLUOROMETHOXY)BENZYLOXY)-6,7-DIHYDRO-5H-IMIDAZO(2,1-B)(1,3)OXAZINE;AKOS024464713;Z1650127771;s1162;D10722;BDBM50363237;SMR004702918;(6S)-2-Nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro- 5H-imidazo[2,1-b][1,3]oxazine;5H-Imidazo(2,1-b)(1,3)oxazine, 6,7-dihydro-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-, (6S)-;(S)-PA 824 (Pretomanid);(3S)-3-(4-TRIFLUOROMETHOXYBENZYLOXY)-6-NITRO-2H-3,4-DIHYDROIMIDAZO(2,1-B)OXAZINE;PRETOMANID [ORANGE BOOK];NCGC00346682-10;PA-824(Pretomanid)?;DS-7321;P2718;CCG-268145;NCGC00346682-02;SR-05000022748;Q7118312;(6S)-2-NITRO-6-{[4-(TRIFLUOROMETHOXY)PHENYL]METHOXY}-5H,6H,7H-IMIDAZO[2,1-B][1,3]OXAZINE;Pretomanid (TN);MFCD06809939;2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine;NS00069334;CS1245;SW220281-1;EX-A1749;187235-37-6;MLS006011141;HY-10844;PRETOMANID [USAN];ZLHZLMOSPGACSZ-NSHDSACASA-N;SCHEMBL2983011;CHEMBL227875;GTPL11172;DB05154;DTXSID8041163;PRETOMANID [WHO-DD];AC-25501;pretomanidum;BRD-K96671969-001-03-1;PA-824(Pretomanid);GLXC-02683;NCGC00346682-01;DA-66440;SR-05000022748-1;PRETOMANID [INN];{4-[((3S)-6-Nitro(2H,3H,4H-imidazolo[2,1-b]1,3-oxazaperhydroin-3-yloxy))methyl]phenoxy}trifluoromethane;PA-824, >=98%
EINECS:
分子式:C14H12F3N3O5
分子量:359.2574
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

(S)-2-硝基-6-[[4-(三氟甲氧基)苄基]氧基]-6,7-二氢-5H-咪唑并[2,1-b][1,3]噁嗪
5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (6S)-;PA-824;(S)-PA 824;(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (...;pretomanid;(S)-6-(4-(trifluoromethoxy)benzyloxy)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;PA824;UNII-2XOI31YC4N;2-NITRO-6(S)-[4-(TRIFLUOROMETHOXY)BENZYLOXY]-6,7-DIHYDRO-5H-IMIDAZO[2,1-B][1,3]OXAZINE;(6S)- 6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-Imidazo[2,1-b][1,3]oxazine;(6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine;(S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine;EOS-60675;(6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine PA-824;PA 824;2XOI31YC4N;MMV688755;(6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine;Pretomanid [USAN:INN];C14H12F3N3O5;AK161427;Pretomanid (USAN/INN);ML;PRETOMANID [MI];(S)-2-NITRO-6-(4-(TRIFLUOROMETHOXY)BENZYLOXY)-6,7-DIHYDRO-5H-IMIDAZO(2,1-B)(1,3)OXAZINE;AKOS024464713;Z1650127771;s1162;D10722;BDBM50363237;SMR004702918;(6S)-2-Nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro- 5H-imidazo[2,1-b][1,3]oxazine;5H-Imidazo(2,1-b)(1,3)oxazine, 6,7-dihydro-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-, (6S)-;(S)-PA 824 (Pretomanid);(3S)-3-(4-TRIFLUOROMETHOXYBENZYLOXY)-6-NITRO-2H-3,4-DIHYDROIMIDAZO(2,1-B)OXAZINE;PRETOMANID [ORANGE BOOK];NCGC00346682-10;PA-824(Pretomanid)?;DS-7321;P2718;CCG-268145;NCGC00346682-02;SR-05000022748;Q7118312;(6S)-2-NITRO-6-{[4-(TRIFLUOROMETHOXY)PHENYL]METHOXY}-5H,6H,7H-IMIDAZO[2,1-B][1,3]OXAZINE;Pretomanid (TN);MFCD06809939;2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine;NS00069334;CS1245;SW220281-1;EX-A1749;187235-37-6;MLS006011141;HY-10844;PRETOMANID [USAN];ZLHZLMOSPGACSZ-NSHDSACASA-N;SCHEMBL2983011;CHEMBL227875;GTPL11172;DB05154;DTXSID8041163;PRETOMANID [WHO-DD];AC-25501;pretomanidum;BRD-K96671969-001-03-1;PA-824(Pretomanid);GLXC-02683;NCGC00346682-01;DA-66440;SR-05000022748-1;PRETOMANID [INN];{4-[((3S)-6-Nitro(2H,3H,4H-imidazolo[2,1-b]1,3-oxazaperhydroin-3-yloxy))methyl]phenoxy}trifluoromethane;PA-824, >=98%